Pharmaceutical Sales 2005

The following is a list of the top 200 pharmaceutical drugs by retail sales in 2005, listed by U.S. sales value and brand name.
New: Quarterly Top 100 prescription sales data now available, from Q1 2011 more....

Top 200 Drugs for 2005 by Sales

View data for: 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012

Rank Drug Current Manufacturer Total Sales ($000) % Change 2004
1 Lipitor Pfizer Inc 6,320,522 6.0%
2 (2) Nexium AstraZeneca Pharmaceuticals, LP 3,436,794 16.0%
3 (1) Prevacid Takeda Pharmaceuticals U.S.A., Inc 3,327,919 4.1%
4 (1) Zocor Merck & Co., Inc. 3,106,628 -1.4%
5 (1) Advair Diskus GlaxoSmithKline 2,830,047 21.8%
6 (1) Zoloft Pfizer Inc 2,561,069 -2.4%
7 (1) Plavix Bristol-Myers Squibb Company 2,480,042 14.3%
8 (1) Effexor XR Pfizer Inc 2,219,469 -2.7%
9 (5) Singulair Merck & Co., Inc. 2,089,348 13.0%
10 (2) Norvasc Pfizer Inc 2,060,364 9.4%
11 Protonix Wyeth 1,957,950 2.5%
12 (3) Ambien Pfizer Inc 1,932,940 12.4%
13 (4) Lexapro Forest Pharmaceuticals, Inc 1,849,528 19.2%
14 (8) Seroquel AstraZeneca Pharmaceuticals, LP 1,718,988 24.7%
15 (6) Actos Takeda Pharmaceuticals U.S.A., Inc 1,605,016 15.6%
16 (3) Zyprexa Eli Lilly and Company 1,577,159 -16.2%
17 (2) Fosamax Merck & Co., Inc. 1,484,088 1.4%
18 (2) Risperdal Janssen Pharmaceuticals, Inc 1,472,597 2.5%
19 (11) Avandia GlaxoSmithKline 1,381,777 31.0%
20 (6) Levaquin Janssen Pharmaceuticals, Inc 1,348,110 19.4%
21 (15) Wellbutrin XL Valeant Pharmaceuticals International 1,326,323 39.8%
22 (4) Pravachol Bristol-Myers Squibb Company 1,315,013 -13.7%
23 (5) Toprol XL AstraZeneca Pharmaceuticals, LP 1,294,098 20.3%
24 (8) OxyContin Purdue Pharma LP 1,285,922 -24.4%
25 (7) Topamax Janssen Pharmaceuticals, Inc 1,267,766 20.5%
26 (17) Celebrex Pfizer Inc 1,241,574 -41.3%
27 (8) Enbrel Amgen Inc. 1,130,642 18.4%
28 (6) Lotrel Novartis Corporation 1,109,867 14.3%
29 (18) Abilify Bristol-Myers Squibb Company 1,098,379 47.0%
30 (1) Zithromax Z-Pak Pfizer Inc 1,096,414 2.4%
31 (2) Zyrtec Johnson & Johnson 1,057,152 4.1%
32 (7) Aciphex Eisai Corporation 1,048,377 -8.0%
33 (4) Flonase GlaxoSmithKline 1,044,160 12.2%
34 (9) Lamictal GlaxoSmithKline 1,031,307 32.1%
35 (10) Adderall XR Shire US Inc 1,007,855 29.6%
36 (6) Valtrex GlaxoSmithKline 978,443 22.0%
37 (14) Allegra Sanofi (formerly Sanofi Aventis) 957,152 -24.1%
38 (39) Mobic Abbott Laboratories 916,397 117.6%
39 (11) Zetia Merck & Co., Inc. 904,129 31.5%
40 (6) Concerta Johnson & Johnson 865,873 13.3%
41 (15) Coreg GlaxoSmithKline 846,802 35.2%
42 (2) Imitrex Oral GlaxoSmithKline 820,211 5.1%
43 (5) Diovan Novartis Corporation 810,581 12.0%
44 (8) Actonel Procter & Gamble 792,582 16.1%
45 (6) Tricor Abbott Laboratories 788,761 15.2%
46 (17) Lantus Sanofi (formerly Sanofi Aventis) 774,711 44.2%
47 (9) Viagra Pfizer Inc 772,235 -14.8%
48 (7) Diovan HCT Novartis Corporation 723,998 15.3%
49 () Vytorin Merck & Co., Inc. 715,174 >999
50 (3) Altace King Pharmaceuticals, Inc. (now part of Pfizer - October 2010) 700,630 6.2%
51 (15) Crestor AstraZeneca Pharmaceuticals, LP 676,848 34.6%
52 (7) Aricept Eisai Corporation 651,887 11.6%
53 (1) Strattera Eli Lilly and Company 642,113 -0.6%
54 (15) Synthroid Abbott Laboratories 640,179 -26.7%
55 (12) Nasonex Merck & Co., Inc. 621,728 24.7%
56 (7) Premarin Tabs Wyeth 616,478 -12.3%
57 Lamisil Oral Novartis Corporation 608,718 0.9%
58 (27) Omnicef Abbott Laboratories 607,482 59.4%
59 (3) Flomax Boehringer Ingelheim Pharmaceuticals, Inc 583,267 7.7%
60 Cozaar Merck & Co., Inc. 580,627 4.0%
61 () Cymbalta Eli Lilly and Company 570,421 926.7%
62 (38) Duragesic Johnson & Johnson 569,671 -52.9%
63 (5) Depakote Abbott Laboratories 563,228 -4.4%
64 (5) Zofran GlaxoSmithKline 554,898 12.0%
65 Detrol LA Pfizer Inc 534,795 5.4%
66 (5) Evista Eli Lilly and Company 505,134 -7.3%
67 (5) Combivent Boehringer Ingelheim Pharmaceuticals, Inc 501,603 10.5%
68 (20) Provigil Cephalon, Inc. (a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd) 496,944 42.5%
69 (6) Pulmicort Respules AstraZeneca Pharmaceuticals, LP 486,297 12.9%
70 (3) Humalog Eli Lilly and Company 484,931 11.2%
71 (29) Lidoderm Endo Pharmaceuticals 470,692 50.0%
72 (9) Cellcept Roche Pharmaceuticals 461,825 15.6%
73 (10) Trileptal Novartis Corporation 458,425 14.9%
74 (2) Hyzaar Merck & Co., Inc. 448,157 4.9%
75 (7) Skelaxin Elan Corporation 445,377 11.5%
76 (19) Yasmin 28 Bayer Healthcare Pharmaceuticals 441,299 34.7%
77 (15) Lovenox Sanofi (formerly Sanofi Aventis) 438,815 32.7%
78 (8) Prograf Astellas Pharma US 431,631 19.2%
79 (17) Depakote ER Abbott Laboratories 428,334 17.9%
80 (2) Ortho Evra Ortho-McNeil-Janssen Pharmaceuticals, Inc. 424,662 3.3%
81 (9) Geodon Oral Pfizer Inc 424,003 25.5%
82 (2) Xalatan Pfizer Inc 409,031 4.8%
83 () Allegra-D 12 Hour Sanofi (formerly Sanofi Aventis) 398,013 -1.4%
84 (26) Humira Abbott Laboratories 394,981 38.0%
85 (6) Procrit Centocor Ortho Biotech, Inc 393,527 -3.1%
86 (12) Combivir GlaxoSmithKline 392,859 -9.4%
87 (24) Niaspan Abbott Laboratories 380,690 33.2%
88 (21) Keppra UCB Inc. 379,564 31.4%
89 (29) Actiq Abbott Laboratories 370,704 41.3%
90 (3) Zithromax Pfizer Inc 358,460 8.6%
91 (23) Clarinex Merck & Co., Inc. 353,325 -27.8%
92 (5) Avapro Bristol-Myers Squibb Company 350,899 8.5%
93 (32) Arimidex AstraZeneca Pharmaceuticals, LP 347,891 44.5%
94 (13) Zithromax Susp 342,532 18.3%
95 (27) Ortho Tri-Cyclen Lo Ortho-McNeil-Janssen Pharmaceuticals, Inc. 339,177 37.2%
96 (2) Asacol Procter & Gamble 339,046 5.2%
97 () Spiriva Boehringer Ingelheim Pharmaceuticals, Inc 337,827 231.9%
98 (57) Paxil CR Apotex Corp 332,100 -59.7%
99 () Truvada Gilead Sciences, Inc. 326,641 >999
100 (21) Zelnorm Novartis Corporation 318,220 26.4%
101 (32) Reyataz Bristol-Myers Squibb Company 313,778 37.6%
102 Nasacort AQ Sanofi (formerly Sanofi Aventis) 311,467 0.6%
103 (1) Sustiva Bristol-Myers Squibb Company 309,140 4.2%
104 (1) Rhinocort Aqua AstraZeneca Pharmaceuticals, LP 296,463 -3.6%
105 (14) Ditropan XL Janssen Pharmaceuticals, Inc 296,169 -11.6%
106 (57) Cialis Eli Lilly and Company 295,191 68.8%
107 (21) Xopenex Sepracor Inc. (renamed Sunovion Pharmaceuticals Inc) 293,131 21.9%
108 (5) Avonex Biogen Idec 292,545 4.2%
109 () Flovent HFA GlaxoSmithKline 289,630 NA
110 (5) Copaxone Sanofi (formerly Sanofi Aventis) 285,940 3.7%
111 (3) Kaletra Abbott Laboratories 284,892 -1.6%
112 (58) Namenda Forest Pharmaceuticals, Inc 283,270 74.9%
113 (6) Patanol Alcon Laboratories, Inc. 277,489 7.8%
114 (27) Viread Gilead Sciences, Inc. 271,732 -22.4%
115 (23) Gleevec Novartis Corporation 270,904 29.8%
116 (18) Avalide Bristol-Myers Squibb Company 268,019 19.1%
117 () Lunesta Sepracor Inc. (renamed Sunovion Pharmaceuticals Inc) 264,331 >999
118 (51) Forteo Eli Lilly and Company 263,801 61.7%
119 (5) Amaryl Sanofi (formerly Sanofi Aventis) 262,732 -5.5%
120 (26) Avandamet GlaxoSmithKline 261,746 -20.7%
121 (3) AndroGel Abbott Laboratories 260,799 7.4%
122 (7) Avelox Bayer Healthcare Pharmaceuticals 259,386 10.2%
123 (113) Neurontin Pfizer Inc 255,121 -87.2%
124 (1) Biaxin XL Abbott Laboratories 255,017 4.1%
125 (20) Trizivir GlaxoSmithKline 253,825 -13.0%
126 (32) Benicar Daiichi Sankyo 251,486 41.4%
127 (38) Elidel Novartis Corporation 250,284 -28.0%
128 (3) Proscar Merck & Co., Inc. 238,949 2.5%
129 (11) Budeprion SR Teva Pharmaceuticals 234,441 14.9%
130 (6) Norvir Abbott Laboratories 231,111 9.0%
131 () Benicar HCT Daiichi Sankyo 227,455 110.5%
132 (5) Aldara Medicis Pharmaceutical Corporation 226,878 8.0%
133 (61) Fuzeon Roche Pharmaceuticals 221,322 71.1%
134 (32) Thalomid Celgene Corporation 217,960 28.5%
135 (8) Cefzil Bristol-Myers Squibb Company 216,930 -9.8%
136 (32) Zofran ODT GlaxoSmithKline 214,014 29.8%
137 (17) Coumadin Tabs Bristol-Myers Squibb Company 209,652 -17.2%
138 (3) Lescol XL Novartis Corporation 208,515 -4.5%
139 (9) Augmentin XR Dr. Reddy's Laboratories Inc. 206,072 -11.9%
140 (10) BenzaClin Sanofi (formerly Sanofi Aventis) 198,676 5.1%
141 (10) Humalog Mix 75/25 Pn 192,707 1.9%
142 (36) Levoxyl King Pharmaceuticals, Inc. (now part of Pfizer - October 2010) 191,394 -34.3%
143 (16) Cosopt Merck & Co., Inc. 190,408 7.7%
144 (1) Trinessa Watson Pharmaceuticals, Inc. (now Actavis, Inc) 186,951 -4.1%
145 (6) Zyrtec Syrup 186,643 -10.6%
146 (15) RenaGel Genzyme Corporation 185,001 5.3%
147 (31) Prilosec AstraZeneca Pharmaceuticals, LP 183,953 -31.1%
148 Alphagan P Allergan, Inc 183,302 -3.4%
149 (34) Tussionex Sanofi (formerly Sanofi Aventis) 181,586 29.6%
150 (18) Endocet Endo Pharmaceuticals 181,043 -21.7%
151 (9) Miacalcin Nasal Novartis Corporation 178,198 -11.7%
152 (3) Inderal LA Wyeth 177,720 -3.7%
153 (4) Klor-Con Upsher-Smith Laboratories Inc. 175,720 -7.2%
154 () Femara Novartis Corporation 173,406 40.5%
155 (27) Mirapex Boehringer Ingelheim Pharmaceuticals, Inc 171,769 19.9%
156 (16) Differin Galderma Laboratories 168,877 4.5%
157 (86) Flovent GlaxoSmithKline 168,481 -63.1%
158 (5) Humulin N Eli Lilly and Company 168,427 -9.1%
159 (17) Temodar Merck & Co., Inc. 168,278 7.9%
160 (48) Ortho Tri-Cyclen Janssen Pharmaceuticals, Inc 168,080 -40.7%
161 (20) Lumigan Allergan, Inc 167,889 13.4%
162 (3) Casodex AstraZeneca Pharmaceuticals, LP 167,447 -2.3%
163 () Arthrotec Pfizer Inc 164,596 39.2%
164 (18) Pegasys Genentech, Inc (member of Roche group) 164,472 -14.2%
165 (6) Zyrtec-D Pfizer Inc 163,573 1.1%
166 (6) Famvir GlaxoSmithKline 163,368 -7.2%
167 (10) Catapres-TTS Boehringer Ingelheim Pharmaceuticals, Inc 163,076 5.8%
168 () Zyvox Pfizer Inc 162,318 28.8%
169 () Relpax Pfizer Inc 162,058 52.9%
170 (14) Xeloda Genentech, Inc (member of Roche group) 162,024 16.0%
171 (17) DuoNeb Dey Pharma 161,270 19.6%
172 (16) Prozac Eli Lilly and Company 158,240 -12.9%
173 () Tamiflu Genentech, Inc (member of Roche group) 157,488 389.2%
174 (4) Tobradex Alcon Laboratories, Inc. 155,102 0.9%
175 () NovoLog Mix 70/30 Novo Nordisk Inc. 155,049 84.6%
176 (22) Amnesteem Mylan Inc. 153,534 -16.9%
177 (78) Ultracet Janssen Pharmaceuticals, Inc 152,802 -52.5%
178 (5) Betaseron Bayer Healthcare Pharmaceuticals 152,108 -4.6%
179 (12) Arava Sanofi (formerly Sanofi Aventis) 151,574 -10.2%
180 (11) Imitrex Inj 149,914 12.1%
181 () Tarceva Astellas Pharma US 149,525 >999
182 (8) Neupogen Amgen Inc. 148,760 -5.5%
183 (4) Atacand AstraZeneca Pharmaceuticals, LP 148,636 -3.0%
184 (153) Bextra Pfizer Inc 148,370 -85.9%
185 () Ketek Pack 148,321 256.5%
186 () Vigamox Alcon Laboratories, Inc. 147,501 36.6%
187 () Aranesp Amgen Inc. 147,016 53.9%
188 () Restasis Allergan, Inc 146,559 67.9%
189 (14) Zomig AstraZeneca Pharmaceuticals, LP 146,078 -7.1%
190 () Pulmozyme Genentech, Inc (member of Roche group) 146,004 23.9%
191 (47) Serevent Diskus GlaxoSmithKline 144,773 -27.8%
192 () Astelin Meda Pharmaceuticals 144,217 19.1%
193 (13) Humulin 70/30 Eli Lilly and Company 142,436 -6.5%
194 () Levitra Bayer Healthcare Pharmaceuticals 141,573 12.5%
195 (3) Zonegran Eisai Corporation 140,681 5.3%
196 (34) DDAVP Sanofi (formerly Sanofi Aventis) 140,623 -19.9%
197 () Caduet Pfizer Inc 139,305 480.3%
198 (11) Prempro Pfizer Inc 136,658 -0.9%
199 (58) Epivir GlaxoSmithKline 135,595 -33.1%
200 () Avinza King Pharmaceuticals, Inc. (now part of Pfizer - October 2010) 135,037 42.3%
All Others 23,609,356 -15.8%

Source: Verispan, VONA

View data for: 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012

Hide
(web1)